French National Registry of Rare Peritoneal Surface Malignancies

• Conditions: Pseudomyxoma Peritonei; Primary Peritoneal Serous Carcinoma; Diffuse Peritoneal Leiomyomatosis; Appendiceal Mucinous Neoplasms; Peritoneal Mesothelioma; Psammocarcinoma; Rare Peritoneal Surface Malignancies; Desmoplastic Small Round Cell Tumor

• Registration Number: NCT02834169
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France.

In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database.

All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-10
• Study First Submitted: 2016-06-30
• Study First Submitted QC: 2016-07-12
• Study First Posted: 2016-07-15
• Status Verified: 2017-08
• Last Update Submitted: 2017-08-18
• Last Update Posted: 2017-08-22
• Primary Completion: 2018-12
• Study Completion: 2018-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2171

Inclusion Criteria

• Patients are eligible if they have a histologically proven rare peritoneal surface malignancy.

Exclusion Criteria

• Histological diagnostic of peritoneal surface malignancy not confirmed
• Expected clinical follow up data not available

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of rare peritoneal surface malignancies	year 5	Collect detailed clinical and histological diagnosis for estimating annual incidence rate

Secondary Outcome Measures

Name	Time	Method
Impact of specific treatment strategies	year 5	Collect detailed therapeutic strategies (surgical procedure, chemotherapy, etc.) on patients with rare peritoneal surface malignancies

Trial Locations

Locations (33)

Institut de Cancérologie de l'Ouest - Paul Papin; 🇫🇷 Angers, France

CHU Jean Minjoz; 🇫🇷 Besancon, France

Institut Bergonié; 🇫🇷 Bordeaux, France

Centre François Baclesse; 🇫🇷 Caen, France

CHU Estaing; 🇫🇷 Clermont-ferrand, France

Centre Jean Perrin; 🇫🇷 Clermont-ferrand, France

AP-HP Louis MOURIER; 🇫🇷 Colombes, France

CHU Bocage; 🇫🇷 Dijon, France

CHU A. Michallon; 🇫🇷 La Tronche, France

Centre Oscar Lambret; 🇫🇷 Lille, France

Scroll for more (23 remaining)